Portal de Periódicos da CAPES

Management of Acute and Recurrent Pericarditis

2020; Elsevier BV; Volume: 75; Issue: 1 Linguagem: Inglês

10.1016/j.jacc.2019.11.021

1558-3597

Juan Guido Chiabrando, Aldo Bonaventura, Alessandra Vecchiè, George F. Wohlford, Adolfo G Mauro, Jennifer H. Jordan, John D. Grizzard, Fabrizio Montecucco, Daniel Berrocal, Antonio Brucato, Massimo Imazio, Antonio Abbate,

Takotsubo Cardiomyopathy and Associated Phenomena

Pericarditis refers to the inflammation of the pericardial layers, resulting from a variety of stimuli triggering a stereotyped immune response, and characterized by chest pain associated often with peculiar electrocardiographic changes and, at times, accompanied by pericardial effusion. Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be complicated by either a large pericardial effusion or tamponade, and carry a significant risk of recurrence. The mainstay of treatment of pericarditis is represented by anti-inflammatory drugs. Anti-inflammatory treatments vary, however, in both effectiveness and side-effect profile. The objective of this review is to summarize the up-to-date management of acute and recurrent pericarditis.